5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 0.45▲ | 0.43▲ |
MA10 | N/A | N/A | N/A | 0.43▲ | 0.40▲ |
MA20 | N/A | N/A | N/A | 0.43▲ | 0.38▲ |
MA50 | N/A | N/A | N/A | 0.39▲ | 0.49▼ |
MA100 | N/A | N/A | N/A | 0.38▲ | 0.42▲ |
MA200 | N/A | N/A | N/A | 0.45▲ | 0.32▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | 0.002▲ | 0.017▲ |
RSI | N/A | N/A | N/A | 60.436▲ | 54.206▲ |
STOCH | N/A | N/A | N/A | 63.260 | 68.627 |
WILL %R | N/A | N/A | N/A | -16.667▲ | -22.000▲ |
CCI | N/A | N/A | N/A | 121.420▲ | 105.214▲ |
Tuesday, April 23, 2024 10:44 AM
The Offer Holders’ Day gives undergraduate applicants with an offer of admission the opportunity to visit the LSE campus, meet LSE students and staff, and find out more about studying at LSE and life ...
|
Friday, April 19, 2024 01:00 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
|
Thursday, April 18, 2024 09:00 AM
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/04/24 | 0.46 | 0.48 | 0.45 | 0.465 | 53,937,784 |
24/04/24 | 0.455 | 0.48 | 0.45 | 0.45 | 55,445,697 |
23/04/24 | 0.425 | 0.46 | 0.41 | 0.455 | 91,241,179 |
22/04/24 | 0.415 | 0.45 | 0.4125 | 0.45 | 77,128,453 |
19/04/24 | 0.415 | 0.43 | 0.40 | 0.415 | 16,147,155 |
18/04/24 | 0.415 | 0.43 | 0.40 | 0.415 | 10,632,208 |
17/04/24 | 0.415 | 0.43 | 0.40 | 0.415 | 36,112,009 |
16/04/24 | 0.415 | 0.43 | 0.40 | 0.40 | 38,610,787 |
15/04/24 | 0.40 | 0.43 | 0.3941 | 0.415 | 40,751,683 |
12/04/24 | 0.425 | 0.43 | 0.39 | 0.40 | 69,481,744 |
|
|
||||
|
|
||||
|
|